Live Breaking News & Updates on United Therapeutics Company Profile

Stay updated with breaking news from United therapeutics company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Analysts Set United Therapeutics Co. (NASDAQ:UTHR) Target Price at $294.25

United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) has received an average recommendation of “Moderate Buy” from the nine analysts that are currently covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 1-year price objective among […] ....

United States , Leerink Partnrs , Livforsakringsbolaget Skandia Omsesidigt , Christopher Patusky , Paula Mahon , United Therapeutics Company Profile , United Therapeutics Corporation , United Therapeutics Co , Securities Exchange Commission , Sg Americas Securities , Goldman Sachs Group , Vontobel Holding Ltd , Asset Management One Co , United Therapeutics , Get Free Report , Therapeutics Trading Down , Exchange Commission , Director Christopher Patusky , Management One , Skandia Omsesidigt , Get Free , Therapeutics Corporation , United Therapeutics Daily , Nasdaq Uthr ,

California Public Employees Retirement System Sells 592 Shares of United Therapeutics Co. (NASDAQ:UTHR)

California Public Employees Retirement System trimmed its stake in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 0.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 256,959 shares of the biotechnology company’s stock after selling 592 […] ....

United States , Paula Mahon , Martinea Rothblatt , Wells Fargo Company , United Therapeutics Corporation , Wealth Partners , Sumitomo Mitsui Ds Asset Management Company Ltd , United Therapeutics Co , Exchange Commission , California Public Employees Retirement System , Securities Exchange Commission , United Therapeutics Company Profile , United Therapeutics , Free Report , Public Employees Retirement System , Sumitomo Mitsui , Management Company Ltd , Get Free Report , Therapeutics Corporation , United Therapeutics Daily , Nasdaq Uthr , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Yousif Capital Management LLC Trims Stock Position in United Therapeutics Co. (NASDAQ:UTHR)

Yousif Capital Management LLC Trims Stock Position in United Therapeutics Co. (NASDAQ:UTHR)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Martinea Rothblatt , Paula Mahon , United Therapeutics Corporation , Comerica Bank , United Therapeutics Co , Exchange Commission , Wells Fargo Company , Goldman Sachs Group , Glenmede Trust Co , Yousif Capital Management , Securities Exchange Commission , United Therapeutics Company Profile , Pacer Advisors Inc , United Therapeutics , Free Report , Capital Management , Get Free Report , Therapeutics Corporation , Visit Holdingschannel , United Therapeutics Daily ,

United Therapeutics Co. (NASDAQ:UTHR) CEO Martine A. Rothblatt Sells 3,600 Shares

United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) CEO Martine A. Rothblatt sold 3,600 shares of the company’s stock in a transaction dated Monday, April 22nd. The shares were sold at an average price of $236.47, for a total value of $851,292.00. Following the sale, the chief executive officer now owns 130 shares in the […] ....

United States , Martinea Rothblatt , Goldman Sachs Group , United Therapeutics Corporation , Cm Bidwell Associates Ltd , Rise Advisors , Ronald Blue Trust Inc , United Therapeutics Company Profile , United Therapeutics Co , Janiczek Wealth Management , United Therapeutics , Get Free Report , Blue Trust , Wealth Management , Therapeutics Corporation , United Therapeutics Daily ,

United Therapeutics Co. (NASDAQ:UTHR) CEO Martine A. Rothblatt Sells 3,600 Shares

United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) CEO Martine A. Rothblatt sold 3,600 shares of the company’s stock in a transaction dated Monday, April 22nd. The shares were sold at an average price of $236.47, for a total value of $851,292.00. Following the sale, the chief executive officer now owns 130 shares in the […] ....

United States , Martinea Rothblatt , United Therapeutics Corporation , Goldman Sachs Group , Cm Bidwell Associates Ltd , Janiczek Wealth Management , United Therapeutics Co , United Therapeutics Company Profile , Ronald Blue Trust Inc , Rise Advisors , United Therapeutics , Get Free Report , Blue Trust , Wealth Management , Therapeutics Corporation , United Therapeutics Daily ,